Related references
Note: Only part of the references are listed.Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
The Inflammasomes: Guardians of the Body
Fablo Martinon et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells
Alexandre Corthay et al.
CANCER RESEARCH (2009)
CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help
Yusuke Nakanishi et al.
NATURE (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
Shlomo Z. Ben-Sasson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
Twelve immunotherapy drugs that could cure cancers
Martin A. ‘Mac’ Cheever
IMMUNOLOGICAL REVIEWS (2008)
Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas:: Long-term results on efficacy and limb salvage in a selected group of patients
Stephane Cherix et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
CD4 regulatory T cells in human cancer pathogenesis
Keith L. Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation
Esther Unitt et al.
JOURNAL OF HEPATOLOGY (2006)
Different patterns of inflammation and prognosis in invasive carcinoma of the breast
AHS Lee et al.
HISTOPATHOLOGY (2006)
Inflammation and prognosis in colorectal cancer
K Klintrup et al.
EUROPEAN JOURNAL OF CANCER (2005)
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer
HE Kohrt et al.
PLOS MEDICINE (2005)
Meta-analysis to evaluate the role of interferon in follicular lymphoma
AZS Rohatiner et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma
N Konishi et al.
ONCOLOGY (2005)
Interleukin 1α promotes Th1 differentiation and inhibits disease progression in Leishmania major -: Susceptible BALB/c mice
E von Stebut et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
IL-1 is required for tumor invasiveness and angiogenesis
E Voronov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunologic parameters as significant prognostic factors in lung cancer
H Nakamura et al.
LUNG CANCER (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNγ receptor expression by nonhematopoietic cells
ZH Qin et al.
IMMUNITY (2000)
Share Paper
